IGFBP5 and cancer: IGFBP-5 exhibits dual behavior across different types of cancers; for instance, while it exerts both anti-tumorigenic and pro-tumorigenic effects on breast and ovarian cancers, its expression is elevated in glioblastoma and colon cancers, suggesting a predominantly pro-tumorigenic behavior in these types of cancers [21].